SETP3
Immune reactions in hematologic diseases

[OS2-11B-5] p53 activation inhibits the development of MLL-fusion leukemia with the assistance of tumor immunity

Yasutaka Hayashi¹, Susumu Goyama¹, Xiaoxiao Liu¹, Shiori Shikata¹, Yosuke Tanaka¹, Tomofusa Fukuyama¹, Akiko Matsumoto², Satoshi Yamasaki², Tatsuhiro Shibata², Hitoshi Takizawa³, Toshio Kitamura¹ (1.Cellular Therapy, IMSUT, Tokyo Univ., Tokyo, Japan, 2.Laboratory of Molecular Medicine, HGC, IMSUT, Tokyo Univ., Tokyo, Japan, 3.International Research Center for Medical Sciences, Kumamoto University, Kumamoto, Japan)